WALTHAM, Mass.--(BUSINESS WIRE)--Nov 8, 2023--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will participate in a fireside chat ...
More than 40% of American adults are considered obese, yet the medications many take are rarely tested in bigger bodies.That's because they are not required to be included in drug studies. And often, they're explicitly excluded.“Clinical trials and dosing instructions don’t always ensure ...
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Nov 7, 2023--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), announced today the presentation of five studies (one oral and four posters) at the annual American College of Rheumatology Convergence 2023 taking ...
PHILADELPHIA--(BUSINESS WIRE)--Nov 7, 2023--BioPhy today launched its AI operating system that radically accelerates the identification and development of the most promising drug candidates. By combining scientific, clinical and regulatory insights with a proprietary operational assessment ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Nov 7, 2023--Grace Science, LLC announced today that it has received FDA clearance of its Investigational New Drug (IND) application for GS-100, an AAV9 gene replacement therapy for the treatment of NGLY1 Deficiency.The clinical trial will utilize a ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov 7, 2023--<a ...
